中國研究人員開發微型連續血糖監測系統，與市場領先的系統一樣有效

CGM感測器由有機電化學電晶體（OECT）製成，比傳統感測器更好地放大訊號雜訊比。

A miniature-sized continuous glucose monitoring (CGM) system has been developed by an interdisciplinary team of researchers from various Chinese universities and shown to work as effectively as market-leading systems.

來自中國多所大學的跨學科研究人員團隊開發了一種微型連續血糖監測（CGM）系統，該系統與市場領先的系統一樣有效。

The CGM sensor is made of an organic electrochemical transistor (OECT), which better amplifies signal-to-noise ratio than conventional sensors. It also features a minimally invasive microneedle array and a viscoelastic and diffusive hydrogel which stabilises the skin-device interface.

CGM感測器由有機電化學電晶體（OECT）製成，比傳統感測器更好地放大訊號雜訊比。它還具有微創微針陣列和黏彈性擴散水凝膠，可穩定皮膚-設備界面。

In a study published in the peer-reviewed Science Advances journal, the OECT showed comparable sensitivity to the Dexcom G6, which was used as a reference device.

在同行評審的 Science Advances 雜誌上發表的一項研究中，OECT 顯示出與用作參考設備的 Dexcom G6 相當的靈敏度。

"This fully integrated, wearable device promises enhanced antinoise ability, reliability, and wearability compared to traditional CGMs," claimed Shiming Zhang, study lead and a professor from The University of Hong Kong (HKU).

研究負責人、香港大學 (HKU) 教授張世明表示：“與傳統 CGM 相比，這種完全整合的可穿戴設備有望增強抗噪音能力、可靠性和耐磨性。”

OECTs, based on organic mixed ion-electron conductors, "can operate in aqueous environments at low voltage with low power consumption while maintaining stable performance over months," researchers noted. This makes it "ideal" for detecting weak biosignals in living beings, they claimed. Until late, its practical application in wearable CGMs was unexplored.

研究人員指出，基於有機混合離子電子導體的 OECT「可以在低電壓、低功耗的水環境中運行，同時保持穩定的性能數月」。他們聲稱，這使得它成為檢測生物體內微弱生物訊號的「理想」選擇。直到最近，它在可穿戴 CGM 中的實際應用尚未被探索。

The research team, comprising professors from HKU, Zhejiang University, and Guangzhou Medical University, is now moving forward with the clinical application of their CGM system.

由香港大學、浙江大學和廣州醫科大學教授組成的研究團隊現已推動動態血糖監測系統的臨床應用。

In China, SiBionics and Zhejiang POCTech are known developers of globally accepted CGM systems.

在中國，SiBionics 和浙江 POCTech 是全球公認的 CGM 系統的知名開發商。

The world's leading CGM brand, Dexcom, has released the latest iteration of its device, which is progressively being made available across Asia-Pacific. It was recently announced that Dexcom G7 is set to provide direct Bluetooth connectivity to the Apple Watch. The device received the United States Food and Drug Administration clearance two years ago.

全球領先的 CGM 品牌 Dexcom 發布了其最新版本的設備，並正在亞太地區逐步上市。最近宣布 Dexcom G7 將提供與 Apple Watch 的直接藍牙連線。該設備兩年前獲得了美國食品和藥物管理局的許可。

Meanwhile, the latest innovation in wearable health technology in Singapore, a hydrogel-based sensor, utilises skin biomarkers to potentially monitor diabetes and heart conditions.

同時，新加坡穿戴式健康技術的最新創新是一種基於水凝膠的感測器，利用皮膚生物標記物來監測糖尿病和心臟病。